REFERENCE
European Medicines Agency.Committee for medicinal products for human use (CHMP) 15-19 February 2010. Internet Document: [21 pages], 25 Feb 2010. Available from: URL: http://www.ema.europa.eu
Rights and permissions
About this article
Cite this article
Labelling changes for Avandia [rosiglitazone], Avandamet [rosiglitazone/metformin] and Avaglim [rosiglitazone/glimepiride]. React. Wkly. 1291, 4 (2010). https://doi.org/10.2165/00128415-201012910-00010
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-201012910-00010